cdmo.directory
← Compare landing

Fujifilm Pharmaceuticals U.S.A., Inc vs TriLink BioTechnologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/fujifilmpharma/trilinkbiotech

CategoryFujifilm Pharmaceuticals U.S.A., IncTriLink BioTechnologies
Listed sitecdmocdmo
SummaryCDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
Services
  • Formulation Development
  • Process Development
  • Lipid Nanoparticle (LNP) Formulation
  • mRNA Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Quality Control Testing
  • Technology Transfer
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
Modalities
  • mRNA
  • Oligonucleotide
  • mRNA
  • Oligonucleotide
Indications
  • Oncology
  • Infectious Disease
Data not yet provided.
LocationsData not yet provided.
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.